SEOUL, Dec. 17 (Korea Bizwire) – South Korea’s first living-donor liver transplant recipient has reached her 30th birthday, three decades after receiving a portion of her father’s liver at just 9 months old. Asan Medical Center in Seoul announced on December 16 that Lee Ji-won, now 30, has marked the 30th anniversary of her groundbreaking transplant [...]
SEOUL, Sept. 29 (Korea Bizwire) — Seoul National University Hospital successfully completed a liver transplant procedure without leaving scars for both the organ donor and recipient using a robot and a laparoscope. The hospital announced on Tuesday that it had succeeded in excising the liver of a donor and transplanting it in a recipient using [...]
SEOUL, Oct. 8 (Korea Bizwire) — A Chilean engineer suffering from liver cancer has miraculously regained health after receiving a liver transplant in South Korea from his two daughters. Alberto, 62, had been working as a civil engineer in Chile when he began to suffer from severe fatigue and jaundice last September. He was soon [...]
SEOUL, Oct. 19 (Korea Bizwire) – Dozens of medical professionals from across Asia are attending the Asian Transplantation Week 2017 to train under South Korean liver transplant specialists, described by Zhaksylyk Doskaliev of Kazakhstan’s National Transplant Coordinating Center as “leading not just Asia but the entire world in pioneering medical treatment”. The symposium, jointly held [...]
SEOUL, Sept. 9 (Korea Bizwire) – Laparoscopic surgery, a form of minimally invasive surgery, is a modern technique in which operations are performed through small incisions (0.5cm – 1.5cm) as an alternative to conventional surgical procedures conducted with open access. Liver transplantation from a living donor is considered to be one of the most complicated [...]
SEOUL, Nov.14 (Korea Bizwire) – Korea’s small s medical start-up firm has successfully completed a clinical test for bio-artificial liver transplant. The research firm has been researching in this area for 15 years investing 12 billion won (US$11 million). Based on its successful clinical experiment, the company plans to enter the bio-artificial organ market by [...]